SCHEMBL8836934

SCHEMBL8836934

C=CCC1CCC(C(=O)O)C1CC=C

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ GABRR1 P24046 5/20 0.36
▸ GABRR2 P28476 1/20 0.36
▸ HCAR2 Q8TDS4 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30158949 0.79 — —
SCHEMBL30158804 0.79 — —
SCHEMBL29187940 0.79 — —
SCHEMBL29187938 0.79 — —
SCHEMBL27477105 0.74 PEPD (0.41) GABRR1GABRR2
SCHEMBL7739490 0.74 PEPD (0.37) GABRR1GABRR2
SCHEMBL17082724 0.73 HSD11B1 (0.32) —
SCHEMBL9173498 0.71 PLG (0.36) GABRR1GABRR2
SCHEMBL19927749 0.68 SLC1A2 (0.36) GABRR1GABRR2
SCHEMBL24850110 0.68 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5641784-A ADENOSINE ANTAGONISTS; TREATMENT OF NERVOUS SYSTEM DISORDERS, ALZHEIMER'S DISEASE BOEHRINGER INGELHEIM KG (DE) 1997-06-24 — — US disclosed
Send feedback